Biorestorative Therapies Inc. (BRTX)
NASDAQ · Healthcare
Biorestorative Therapies Inc. Operating Income 2011–2025
Biorestorative Therapies Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Biorestorative Therapies Inc. operating income for the quarter ending March 31, 2026 was -3.4 M, a 29.57% decrease year-over-year.
- Biorestorative Therapies Inc. operating income for the twelve months ending March 31, 2026 was -15.2 M, a 27.05% increase year-over-year.
- Biorestorative Therapies Inc. annual operating income for 2025 was -15.6 M, a 35.41% increase from 2024.
- Biorestorative Therapies Inc. annual operating income for 2024 was -11.6 M, a 24.08% decrease from 2023.
- Biorestorative Therapies Inc. annual operating income for 2023 was -15.2 M, a 19.78% decrease from 2022.
- Biorestorative Therapies Inc. annual operating income for 2022 was -19.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biorestorative Therapies Inc. Operating Income — FAQ
Biorestorative Therapies Inc. (BRTX) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Biorestorative Therapies Inc.'s operating income?
Biorestorative Therapies Inc. (BRTX) reported operating income of -$16M for fiscal 2025.
Where can I see BRTX's operating income history?
The chart and table above show Biorestorative Therapies Inc.'s operating income by year and by quarter, including the growth rate.